This compound is a pharmaceutical intermediate used in the manufacturing of olmesartan medoxomil, an angiotensin II receptor blocker. It is a high-molecular-weight, lipophilic molecule containing multiple aromatic rings and several functional groups, including an ester and an alcohol.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 144690-92-6
N2-tritylolmesartan medoxomil
pharmaceutical intermediate for research and manufacturing
Ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)methyl)-1h-imidazole-5-carboxylate
pharmaceutical intermediate
4-(2-Hydroxypropan-2-yl)-2-propyl-1-({2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl}methyl)-1H-imidazole-5-carboxylic acid
pharmaceutical intermediate
Olmesartan medoxomil
pharmaceutical raw material
(S)-(+)-1-Methoxy-2-propanol
pharmaceutical intermediate
Carbic anhydride
pharmaceutical intermediate
4-Methoxytriphenylmethyl chloride
pharmaceutical intermediate
Desacetyl-7-desmethyl Agomelatine Hydrobromide
pharmaceutical intermediate
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
IJOPLMOXIPGJIJ-UHFFFAOYSA-N
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=NN4C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)C(=O)OCC8=C(OC(=O)O8)C)C(C)(C)O